1. Home
  2. AMED vs HAE Comparison

AMED vs HAE Comparison

Compare AMED & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMED
  • HAE
  • Stock Information
  • Founded
  • AMED 1982
  • HAE 1971
  • Country
  • AMED United States
  • HAE United States
  • Employees
  • AMED N/A
  • HAE N/A
  • Industry
  • AMED Medical/Nursing Services
  • HAE Medical/Dental Instruments
  • Sector
  • AMED Health Care
  • HAE Health Care
  • Exchange
  • AMED Nasdaq
  • HAE Nasdaq
  • Market Cap
  • AMED 3.2B
  • HAE 3.3B
  • IPO Year
  • AMED N/A
  • HAE 1991
  • Fundamental
  • Price
  • AMED $97.46
  • HAE $72.56
  • Analyst Decision
  • AMED Hold
  • HAE Strong Buy
  • Analyst Count
  • AMED 5
  • HAE 10
  • Target Price
  • AMED $100.80
  • HAE $99.00
  • AVG Volume (30 Days)
  • AMED 427.7K
  • HAE 570.6K
  • Earning Date
  • AMED 07-28-2025
  • HAE 08-07-2025
  • Dividend Yield
  • AMED N/A
  • HAE N/A
  • EPS Growth
  • AMED N/A
  • HAE 44.54
  • EPS
  • AMED 2.72
  • HAE 3.31
  • Revenue
  • AMED $2,371,691,000.00
  • HAE $1,360,824,000.00
  • Revenue This Year
  • AMED $6.29
  • HAE N/A
  • Revenue Next Year
  • AMED $5.29
  • HAE $7.26
  • P/E Ratio
  • AMED $35.91
  • HAE $21.85
  • Revenue Growth
  • AMED 5.34
  • HAE 3.96
  • 52 Week Low
  • AMED $82.15
  • HAE $55.30
  • 52 Week High
  • AMED $98.95
  • HAE $94.99
  • Technical
  • Relative Strength Index (RSI)
  • AMED 55.48
  • HAE 46.26
  • Support Level
  • AMED $96.99
  • HAE $74.45
  • Resistance Level
  • AMED $97.87
  • HAE $76.83
  • Average True Range (ATR)
  • AMED 0.64
  • HAE 2.08
  • MACD
  • AMED -0.09
  • HAE -0.60
  • Stochastic Oscillator
  • AMED 67.01
  • HAE 6.35

About AMED Amedisys Inc

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, and high acuity care segment. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States; the Hospice segment operates many centers designed to provide comfort and support for terminally ill patients; and the High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: